|
1
|
Charlton OA, Harris V, Phan K, Mewton E,
Jackson C and Cooper A: Toxic epidermal necrolysis and
Steven-Johnson syndrome: A comprehensive review. Adv Wound Care
(New Rochelle). 9:426–439. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mockenhaupt M: Stevens-Johnson syndrome
and toxic epidermal necrolysis: Clinical patterns, diagnostic
considerations, etiology, and therapeutic management. Semin Cutan
Med Surg. 33:10–16. 2014.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Duong TA, Valeyrie-Allanore L, Wolkenstein
P and Chosidow O: Severe cutaneous adverse reactions to drugs.
Lancet. 390:1996–2011. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Oakley AM and Krishnamurthy K:
Stevens-Johnson syndrome. StatPearls. Treasure Island (FL):
StatPearls Publishing Copyright ©. 2026, StatPearls Publishing
LLC., 2026.
|
|
5
|
Zahra FT, Imtiaz A, Khan A and Fatima M:
JAK inhibitors in toxic epidermal necrolysis a new frontier in
therapeutics. Ann Med Surg (Lond). 88:1206–1208. 2026.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Murphy TJ, Fijany AJ, Swafford EP, Garcia
JT, Vyas P, Beyene RT, Gondek SP, Wagner AL, Patel MB and Slater
ED: The outcomes of SJS/TEN: A nationwide analysis. J Burn Care
Res: irag010, 2026 (Epub ahead of print).
|
|
7
|
Schneider JA and Cohen PR: Stevens-Johnson
syndrome and toxic epidermal necrolysis: A concise review with a
comprehensive summary of therapeutic interventions emphasizing
supportive measures. Adv Ther. 34:1235–1244. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Creamer D, Walsh SA, Dziewulski P, Exton
LS, Lee HY, Dart JKG, Setterfield J, Bunker CB, Ardern-Jones MR,
Watson KMT, et al: UK guidelines for the management of
Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.
J Plast Reconstr Aesthet Surg. 69:e119–e153. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Yamane Y, Matsukura S, Watanabe Y,
Yamaguchi Y, Nakamura K, Kambara T, Ikezawa Z and Aihara M:
Retrospective analysis of Stevens-Johnson syndrome and toxic
epidermal necrolysis in 87 Japanese patients-treatment and outcome.
Allergol Int. 65:74–81. 2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zimmermann S, Sekula P, Venhoff M,
Motschall E, Knaus J, Schumacher M and Mockenhaupt M: Systemic
immunomodulating therapies for Stevens-Johnson syndrome and toxic
epidermal necrolysis: A systematic review and meta-analysis. JAMA
Dermatol. 153:514–522. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Chung WH, Hung SI, Yang JY, Su SC, Huang
SP, Wei CY, Chin SW, Chiou CC, Chu SC, Ho HC, et al: Granulysin is
a key mediator for disseminated keratinocyte death in
Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med.
14:1343–1350. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Chung WH, Hung SI, Hong HS, Hsih MS, Yang
LC, Ho HC, Wu JY and Chen YT: Medical genetics: A marker for
Stevens-Johnson syndrome. Nature. 428(486)2004.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
White KD, Abe R, Ardern-Jones M,
Beachkofsky T, Bouchard C, Carleton B, Chodosh J, Cibotti R, Davis
R, Denny JC, et al: SJS/TEN 2017: Building multidisciplinary
networks to drive science and translation. J Allergy Clin Immunol
Pract. 6:38–69. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ivanov II, McKenzie BS, Zhou L, Tadokoro
CE, Lepelley A, Lafaille JJ, Cua DJ and Littman DR: The orphan
nuclear receptor RORgammat directs the differentiation program of
proinflammatory IL-17+ T helper cells. Cell. 126:1121–1133.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Harrington LE, Hatton RD, Mangan PR,
Turner H, Murphy TL, Murphy KM and Weaver CT: Interleukin
17-producing CD4+ effector T cells develop via a lineage distinct
from the T helper type 1 and 2 lineages. Nat Immunol. 6:1123–1132.
2005.PubMed/NCBI View
Article : Google Scholar
|
|
16
|
Zhu J and Paul WE: CD4 T cells: Fates,
functions, and faults. Blood. 112:1557–1569. 2008.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hori S, Nomura T and Sakaguchi S: Control
of regulatory T cell development by the transcription factor Foxp3.
Science. 299:1057–1061. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Brunkow ME, Jeffery EW, Hjerrild KA,
Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF
and Ramsdell F: Disruption of a new forkhead/winged-helix protein,
scurfin, results in the fatal lymphoproliferative disorder of the
scurfy mouse. Nat Genet. 27:68–73. 2001.PubMed/NCBI View
Article : Google Scholar
|
|
19
|
Noack M and Miossec P: Th17 and regulatory
T cell balance in autoimmune and inflammatory diseases. Autoimmun
Rev. 13:668–677. 2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Lee GR: The balance of Th17 versus treg
cells in autoimmunity. Int J Mol Sci. 19(730)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Nistala K and Wedderburn LR: Th17 and
regulatory T cells: Rebalancing pro- and anti-inflammatory forces
in autoimmune arthritis. Rheumatology (Oxford). 48:602–606.
2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tapia B, Padial A, Sánchez-Sabaté E,
Alvarez-Ferreira J, Morel E, Blanca M and Bellón T: Involvement of
CCL27-CCR10 interactions in drug-induced cutaneous reactions. J
Allergy Clin Immunol. 114:335–340. 2004.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Stern RS and Divito SJ: Stevens-Johnson
syndrome and toxic epidermal necrolysis: Associations, outcomes,
and pathobiology-thirty years of progress but still much to be
done. J Invest Dermatol. 137:1004–1008. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Tohyama M, Watanabe H, Murakami S,
Shirakata Y, Sayama K, Iijima M and Hashimoto K: Possible
involvement of CD14+ CD16+ monocyte lineage cells in the epidermal
damage of Stevens-Johnson syndrome and toxic epidermal necrolysis.
Br J Dermatol. 166:322–330. 2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Paquet P and Piérard GE: Soluble fractions
of tumor necrosis factor-alpha, interleukin-6 and of their
receptors in toxic epidermal necrolysis: A comparison with
second-degree burns. Int J Mol Med. 1:459–462. 1998.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Nassif A, Bensussan A, Dorothée G,
Mami-Chouaib F, Bachot N, Bagot M, Boumsell L and Roujeau JC: Drug
specific cytotoxic T-cells in the skin lesions of a patient with
toxic epidermal necrolysis. J Invest Dermatol. 118:728–733.
2002.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Schwartz RA, McDonough PH and Lee BW:
Toxic epidermal necrolysis: Part II. Prognosis, sequelae,
diagnosis, differential diagnosis, prevention, and treatment. J Am
Acad Dermatol. 69:187.e1-e16. 203–204. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Tian CC, Ai XC, Ma JC, Hu FQ, Liu XT, Luo
YJ, Tan GZ, Zhang JM, Li XQ, Guo Q, et al: Etanercept treatment of
Stevens-Johnson syndrome and toxic epidermal necrolysis. Ann
Allergy Asthma Immunol. 129:360–365.e1. 2022.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cao J, Zhang X, Xing X and Fan J: Biologic
TNF-α inhibitors for Stevens-Johnson syndrome, toxic epidermal
necrolysis, and TEN-SJS overlap: A study-level and patient-level
meta-analysis. Dermatol Ther (Heidelb). 13:1305–1327.
2023.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Wang H, Zhang JX, Li SL, Wang F, Zha WS,
Shen T, Wu C and Zhu QX: An animal model of
trichloroethylene-induced skin sensitization in BALB/c mice. Int J
Toxicol. 34:442–453. 2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Azukizawa H: Animal models of toxic
epidermal necrolysis. J Dermatol. 38:255–260. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Böyum A: Isolation of mononuclear cells
and granulocytes from human blood. Isolation of monuclear cells by
one centrifugation, and of granulocytes by combining centrifugation
and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 97:77–89.
1968.PubMed/NCBI
|
|
33
|
Enerbäck L: Mast cells in rat
gastrointestinal mucosa. 2. Dye-binding and metachromatic
properties. Acta Pathol Microbiol Scand. 66:303–312.
1966.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ramos-Vara JA: Technical aspects of
immunohistochemistry. Vet Pathol. 42:405–426. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Annunziato F, Cosmi L, Santarlasci V,
Maggi L, Liotta F, Mazzinghi B, Parente E, Filì L, Ferri S, Frosali
F, et al: Phenotypic and functional features of human Th17 cells. J
Exp Med. 204:1849–1861. 2007.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Wang CW, Yang LY, Chen CB, Ho HC, Hung SI,
Yang CH, Chang CJ, Su SC, Hui RCY, Chin SW, et al: Randomized,
controlled trial of TNF-α antagonist in CTL-mediated severe
cutaneous adverse reactions. J Clin Invest. 128:985–996.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Teraki Y, Kawabe M and Izaki S: Possible
role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome
and toxic epidermal necrolysis. J Allergy Clin Immunol.
131:907–909. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zhou L, Lopes JE, Chong MMW, Ivanov II,
Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, et al:
TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by
antagonizing RORgammat function. Nature. 453:236–240.
2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ueta M, Kannabiran C, Wakamatsu TH, Kim
MK, Yoon KC, Seo KY, Joo CK, Sangwan V, Rathi V, Basu S, et al:
Trans-ethnic study confirmed independent associations of
HLA-A*02:06 and HLA-B*44:03 with cold medicine-related
Stevens-Johnson syndrome with severe ocular surface complications.
Sci Rep. 4(5981)2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ushigome Y, Mizukawa Y, Kimishima M,
Yamazaki Y, Takahashi R, Kano Y and Shiohara T: Monocytes are
involved in the balance between regulatory T cells and Th17 cells
in severe drug eruptions. Clin Exp Allergy. 48:1453–1463.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sun L, Zhao Q, Ao S, Liu T, Wang Z, You J,
Mi Z, Sun Y, Xue X, Ogese MO, et al: Feedback regulation of VISTA
and Treg by TNF-α controls T cell responses in drug allergy.
Allergy. 80:1400–1416. 2025.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hama N, Aoki S, Chen CB, Hasegawa A, Ogawa
Y, Vocanson M, Asada H, Chu CY, Lan CCE, Dodiuk-Gad RP, et al:
Recent progress in Stevens-Johnson syndrome/toxic epidermal
necrolysis: Diagnostic criteria, pathogenesis and treatment. Br J
Dermatol. 192:9–18. 2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Chen CB, Abe R, Pan RY, Wang CW, Hung SI,
Tsai YG and Chung WH: An updated review of the molecular mechanisms
in drug hypersensitivity. J Immunol Res.
2018(6431694)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Milojevic D, Nguyen KD, Wara D and Mellins
ED: Regulatory T cells and their role in rheumatic diseases: A
potential target for novel therapeutic development. Pediatr
Rheumatol Online J. 6(20)2008.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Zhang S, Tang S, Li S, Pan Y and Ding Y:
Biologic TNF-alpha inhibitors in the treatment of Stevens-Johnson
syndrome and toxic epidermal necrolysis: A systemic review. J
Dermatolog Treat. 31:66–73. 2020.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Heuer R, Paulmann M, Mockenhaupt M and
Nast A: Systemic immunomodulating therapies for epidermal
necrolysis (Stevens-Johnson syndrome/toxic epidermal necrolysis): A
systematic review and meta-analysis. J Dtsch Dermatol Ges.
24:34–42. 2026.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Umemura M, Okamoto-Yoshida Y, Yahagi A,
Touyama S, Nakae S, Iwakura Y and Matsuzaki G: Involvement of
IL-17A-producing TCR γδ T cells in late protective immunity against
pulmonary Mycobacterium tuberculosis infection. Immun Inflamm Dis.
4:401–412. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Roujeau JC: The spectrum of
Stevens-Johnson syndrome and toxic epidermal necrolysis: A clinical
classification. J Invest Dermatol. 102:28S–30S. 1994.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Roujeau JC: Treatment of severe drug
eruptions. J Dermatol. 26:718–722. 1999.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yao L, Baltatzis S, Zafirakis P,
Livir-Rallatos C, Voudouri A, Markomichelakis N, Zhao T and Foster
CS: Human mast cell subtypes in conjunctiva of patients with atopic
keratoconjunctivitis, ocular cicatricial pemphigoid and
Stevens-Johnson syndrome. Ocul Immunol Inflamm. 11:211–222.
2003.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yu X, Kasprick A, Hartmann K and Petersen
F: The role of mast cells in autoimmune bullous dermatoses. Front
Immunol. 9(386)2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Suurmond J, van Heemst J, van Heiningen J,
Dorjée AL, Schilham MW, van der Beek FB, Huizinga TW, Schuerwegh
AJM and Toes REM: Communication between human mast cells and CD4(+)
T cells through antigen-dependent interactions. Eur J Immunol.
43:1758–1768. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Chatterjea D, Paredes L, Martinov T,
Balsells E, Allen J, Sykes A and Ashbaugh A: TNF-alpha neutralizing
antibody blocks thermal sensitivity induced by compound
48/80-provoked mast cell degranulation. F1000Res.
2(178)2013.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Wershil BK, Furuta GT, Lavigne JA,
Choudhury AR, Wang ZS and Galli SJ: Dexamethasone or cyclosporin A
suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms
of inhibition of IgE- and mast cell-dependent cutaneous
inflammation in the mouse. J Immunol. 154:1391–1398.
1995.PubMed/NCBI
|
|
56
|
Yang XO, Pappu BP, Nurieva R, Akimzhanov
A, Kang HS, Chung Y, Ma L, Shah B, Panopoulos AD, Schluns KS, et
al: T helper 17 lineage differentiation is programmed by orphan
nuclear receptors ROR alpha and ROR gamma. Immunity. 28:29–39.
2008.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Pandiyan P, Zheng L, Ishihara S, Reed J
and Lenardo MJ: CD4+CD25+Foxp3+ regulatory T cells induce cytokine
deprivation-mediated apoptosis of effector CD4+ T cells. Nat
Immunol. 8:1353–1362. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
58
|
Acosta-Rodriguez EV, Rivino L, Geginat J,
Jarrossay D, Gattorno M, Lanzavecchia A, Sallusto F and Napolitani
G: Surface phenotype and antigenic specificity of human interleukin
17-producing T helper memory cells. Nat Immunol. 8:639–646.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
59
|
Hung SI, Mockenhaupt M, Blumenthal KG, Abe
R, Ueta M, Ingen-Housz-Oro S, Phillips EJ and Chung WH: Severe
cutaneous adverse reactions. Nat Rev Dis Primers.
10(30)2024.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Irani Y, Scotney P, Nash A and Williams
KA: Species cross-reactivity of antibodies used to treat ophthalmic
conditions. Invest Ophthalmol Vis Sci. 57:586–591. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Shen C, Maerten P, Geboes K, Van Assche G,
Rutgeerts P and Ceuppens JL: Infliximab induces apoptosis of
monocytes and T lymphocytes in a human-mouse chimeric model. Clin
Immunol. 115:250–259. 2005.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Lopetuso LR, Petito V, Cufino V, Arena V,
Stigliano E, Gerardi V, Gaetani E, Poscia A, Amato A, Cammarota G,
et al: Locally injected Infliximab ameliorates murine DSS colitis:
Differences in serum and intestinal levels of drug between healthy
and colitic mice. Dig Liver Dis. 45:1017–1021. 2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Gibson A, Ram R, Gangula R, Li Y,
Mukherjee E, Palubinsky AM, Campbell CN, Thorne M, Konvinse KC,
Choshi P, et al: Multiomic single-cell sequencing defines
tissue-specific responses in Stevens-Johnson syndrome and toxic
epidermal necrolysis. Nat Commun. 15(8722)2024.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Zhou L, Lu Y, Zou Y, Wei H, Guo X, Li Q,
Zhou Y, Zhao X, Xie F and Zhang L: Drug-induced Stevens-Johnson
syndrome and toxic epidermal necrolysis: A 10-year retrospective
study of 103 cases. Clin Exp Dermatol. 50:2200–2208.
2025.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Chung WH, Chang WC, Lee YS, Wu YY, Yang
CH, Ho HC, Chen MJ, Lin JY, Hui RC, Ho JC, et al: Genetic variants
associated with phenytoin-related severe cutaneous adverse
reactions. JAMA. 312:525–534. 2014.PubMed/NCBI View Article : Google Scholar
|
